GLP-1 Use Among Young Children With Obesity in US Remains Rare but Is Rising Rapidly
September 04, 2026
September 04, 2026
NEW YORK, Sept. 4 [Category: BizHospital] -- NYU Langone Health, an academic medical center affiliated with New York University, posted the following news release:
* * *
GLP-1 Use Among Young Children With Obesity in US Remains Rare but Is Rising Rapidly
*
Although the number of US children under age 12 with obesity being prescribed the weight loss drugs Saxenda, Wegovy, and Zepbound remains low, the number is 310 times higher in June 2026 than . . .
* * *
GLP-1 Use Among Young Children With Obesity in US Remains Rare but Is Rising Rapidly
*
Although the number of US children under age 12 with obesity being prescribed the weight loss drugs Saxenda, Wegovy, and Zepbound remains low, the number is 310 times higher in June 2026 than . . .